LP-284 targets DNA repair defects in cancers, showing promise in preclinical and early clinical trials across multiple cancer types. The FDA's orphan drug designation supports LP-284's development for ...

CLD-201, an allogeneic adipose stem-cell loaded oncolytic virus, received FDA fast track designation for soft tissue sarcoma treatment. Fast track designation expedites drug development and review for ...

Miami Dolphins center Aaron Brewer has been unable to practice yet this training camp and has been doing work on the side. It was revealed Friday at Mike McDaniel’s media session that Brewer has a ...

A new editorial was published in Volume 16 of Oncotarget on July 16, 2025, titled "microRNAs in soft tissue sarcoma: State of the art and barriers to translation." In this article, Elizaveta K.

NORFOLK, Va. (WAVY) — Sarcoma, one of the rarest cancers in the world, makes up just 1% of all adult cancer diagnoses, but it is widely recognized as the ‘forgotten cancer,’ putting emphasis on just ...

Munich, Germany – June 24, 2025 – Thermosome GmbH, a clinical-stage drug development company focused on targeted tumor therapies, today announced new, encouraging data from its ongoing Phase I ...

This retrospective cohort study of limb-sparing eSTS resections integrated clinical variables and radiomic features, including eSTS and limb dimensions. Target outcomes included surgical site ...

A recent study has demonstrated that a precision medicine approach improves treatment selection for patients with soft tissue sarcomas (STS) in a clinical setting. Published in npj Precision Oncology ...

A recent analysis reveals that the incidence rates of soft tissue sarcomas - cancers in muscle, fat, blood vessels, nerves, and tendons - are lower in young U.S. active-duty military servicemen ...

Efti in combination with pembrolizumab and radiotherapy demonstrates significant efficacy in the neoadjuvant setting in patients with soft tissue sarcoma Over three-fold increase in tumour ...